203 related articles for article (PubMed ID: 36582061)
21. From rational design to serendipity: Discovery of novel thiosemicarbazones as potent trypanocidal compounds.
Braga SFP; Santos VC; Vieira RP; Silva EBD; Monti L; Krake SH; Martinez PDG; Dias LC; Caffrey CR; Siqueira-Neto JL; de Oliveira RB; Ferreira RS
Eur J Med Chem; 2022 Dec; 244():114876. PubMed ID: 36343429
[TBL] [Abstract][Full Text] [Related]
22. Discovery of 2-(1H-imidazo-2-yl)piperazines as a new class of potent and non-cytotoxic inhibitors of Trypanosoma brucei growth in vitro.
Ferrigno F; Biancofiore I; Malancona S; Ponzi S; Paonessa G; Graziani R; Bresciani A; Gennari N; Di Marco A; Kaiser M; Summa V; Harper S; Ontoria JM
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3689-3692. PubMed ID: 30482621
[TBL] [Abstract][Full Text] [Related]
23. Antimicrobial Peptides (AMPs): Potential Therapeutic Strategy against Trypanosomiases?
Rojas-Pirela M; Kemmerling U; Quiñones W; Michels PAM; Rojas V
Biomolecules; 2023 Mar; 13(4):. PubMed ID: 37189347
[TBL] [Abstract][Full Text] [Related]
24. Diamidine activity against trypanosomes: the state of the art.
Soeiro MN; de Castro SL; de Souza EM; Batista DG; Silva CF; Boykin DW
Curr Mol Pharmacol; 2008 Jun; 1(2):151-61. PubMed ID: 20021429
[TBL] [Abstract][Full Text] [Related]
25. Multitask learning-driven identification of novel antitrypanosomal compounds.
Lemos JM; Brito da Silva MF; Dos Santos Carvalho AM; Vicente Gil HP; Fiaia Costa VA; Andrade CH; Braga RC; Grellier P; Muratov EN; Charneau S; Moreira-Filho JT; Dourado Bastos IM; Neves BJ
Future Med Chem; 2023 Aug; 15(16):1449-1467. PubMed ID: 37701989
[No Abstract] [Full Text] [Related]
26. Synthesis and Structure-Activity Relationships of Imidazopyridine/Pyrimidine- and Furopyridine-Based Anti-infective Agents against Trypanosomiases.
Silva DG; Junker A; de Melo SMG; Fumagalli F; Gillespie JR; Molasky N; Buckner FS; Matheeussen A; Caljon G; Maes L; Emery FS
ChemMedChem; 2021 Mar; 16(6):966-975. PubMed ID: 33078573
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic Potential of Flavonoid Derivatives for Certain Neglected Tropical Diseases.
Pone BK; Ferreira EI
Curr Drug Targets; 2022; 23(7):680-682. PubMed ID: 35264087
[TBL] [Abstract][Full Text] [Related]
28. Sterol 14alpha-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasis.
Lepesheva GI; Waterman MR
Curr Top Med Chem; 2011; 11(16):2060-71. PubMed ID: 21619513
[TBL] [Abstract][Full Text] [Related]
29. The discovery of aryl-2-nitroethyl triamino pyrimidines as anti-Trypanosoma brucei agents.
Linciano P; Pozzi C; Tassone G; Landi G; Mangani S; Santucci M; Luciani R; Ferrari S; Santarem N; Tagliazucchi L; Cordeiro-da-Silva A; Tonelli M; Tondi D; Bertarini L; Gul S; Witt G; Moraes CB; Costantino L; Costi MP
Eur J Med Chem; 2024 Jan; 264():115946. PubMed ID: 38043491
[TBL] [Abstract][Full Text] [Related]
30. Biological characterization of chemically diverse compounds targeting the Plasmodium falciparum coenzyme A synthesis pathway.
Fletcher S; Lucantoni L; Sykes ML; Jones AJ; Holleran JP; Saliba KJ; Avery VM
Parasit Vectors; 2016 Nov; 9(1):589. PubMed ID: 27855724
[TBL] [Abstract][Full Text] [Related]
31. Insight into Recent Drug Discoveries against Trypanosomatids and Plasmodium spp Parasites: New Metal-based Compounds.
Scarim CB; de Farias RL; Chiba DE; Chin CM
Curr Med Chem; 2022; 29(13):2334-2381. PubMed ID: 34533436
[TBL] [Abstract][Full Text] [Related]
32. Anilinoquinoline based inhibitors of trypanosomatid proliferation.
Ferrins L; Sharma A; Thomas SM; Mehta N; Erath J; Tanghe S; Leed SE; Rodriguez A; Mensa-Wilmot K; Sciotti RJ; Gillingwater K; Pollastri MP
PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006834. PubMed ID: 30475800
[TBL] [Abstract][Full Text] [Related]
33. Secondary metabolites from Vietnamese marine invertebrates with activity against Trypanosoma brucei and T. cruzi.
Thao NP; No JH; Luyen BT; Yang G; Byun SY; Goo J; Kim KT; Cuong NX; Nam NH; Van Minh C; Schmidt TJ; Kang JS; Kim YH
Molecules; 2014 Jun; 19(6):7869-80. PubMed ID: 24962391
[TBL] [Abstract][Full Text] [Related]
34. [Rational concepts and the study of active molecules against various trypanosomiases].
Périé J; de Albuquerque C; Blonski C; Chauvière G; Gefflaut T; Page P; Trinquier M; Willson M
Bull Soc Pathol Exot; 1994; 87(5):353-61. PubMed ID: 7496200
[TBL] [Abstract][Full Text] [Related]
35. Trypanocidal drugs: mechanisms, resistance and new targets.
Wilkinson SR; Kelly JM
Expert Rev Mol Med; 2009 Oct; 11():e31. PubMed ID: 19863838
[TBL] [Abstract][Full Text] [Related]
36. Advances in Drug Discovery against Neglected Tropical Diseases: Human African and American Trypanosomiasis.
Peerzada MN; Gaur A; Azam A
Curr Med Chem; 2021; 28(36):7544-7582. PubMed ID: 33949927
[TBL] [Abstract][Full Text] [Related]
37. Protein farnesyl transferase inhibitors for the treatment of malaria and African trypanosomiasis.
Buckner FS; Eastman RT; Yokoyama K; Gelb MH; Van Voorhis WC
Curr Opin Investig Drugs; 2005 Aug; 6(8):791-7. PubMed ID: 16121685
[TBL] [Abstract][Full Text] [Related]
38. Protective activity of biflavanones from Garcinia kola against Plasmodium infection.
Konziase B
J Ethnopharmacol; 2015 Aug; 172():214-8. PubMed ID: 26129936
[TBL] [Abstract][Full Text] [Related]
39. The kinetoplastid chemotherapy revisited: current drugs, recent advances and future perspectives.
Castillo E; Dea-Ayuela MA; Bolás-Fernández F; Rangel M; González-Rosende ME
Curr Med Chem; 2010; 17(33):4027-51. PubMed ID: 20939823
[TBL] [Abstract][Full Text] [Related]
40. Antiparasitic activities of two sesquiterpenic lactones isolated from Acanthospermum hispidum D.C.
Ganfon H; Bero J; Tchinda AT; Gbaguidi F; Gbenou J; Moudachirou M; Frédérich M; Quetin-Leclercq J
J Ethnopharmacol; 2012 May; 141(1):411-7. PubMed ID: 22440261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
